Get started
Author

Noha A. El‐Bassiouny

Observed names: El‑Bassiouny, Noha A., Noha A El-Bassiouny, Noha A El‑Bassiouny, Noha A. El Bassiouny, Noha A. El-Bassiouny, Noha A. El‑Bassiouny, Noha A.El-Bassiouny, Noha Ahmed El-Bassiouny, Noha El-Bassiouny, Noha El-bassiouny
Observed institution: Damanhour University
ORCID: 0000-0001-9277-2910
Observed ORCID: 0000-0001-9277-2910
OpenAlex ID: A5026828890
The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study
2023 · Manar A. Serageldin, Amira B. Kassem, et al. · Drug Safety · 45
PDF
Metformin may protect nondiabetic breast cancer women from metastasis
2016 · Sahar Mohammed EL-Haggar, Nagla A. El-Shitany, et al. · Clinical & Experimental Metastasis · 42
An emergency plan for management of COVID‐19 patients in rural areas
2021 · Ahmad Z. Al Meslamani, Amira B. Kassem, et al. · International Journal of Clinical Practice · 40
The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy
2022 · Noha A. El-Bassiouny, Maged W. Helmy, et al. · Clinical Breast Cancer · 31
Polymorphic renal transporters and cisplatin’s toxicity in urinary bladder cancer patients: current perspectives and future directions
2023 · Mohamed S. Selim, Amira B. Kassem, et al. · Medical Oncology · 23
PDF
A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study
2024 · Manar A. Serageldin, Noha A. El‐Bassiouny, et al. · British Journal of Clinical Pharmacology · 11
PDF
Community pharmacists’ needs, education, and readiness in facing COVID‐19: Actions & recommendations in Egypt
2021 · Amira B. Kassem, Asser I. Ghoneim, et al. · International Journal of Clinical Practice · 10
PDF
Assessment and analysis of outpatient medication errors related to pediatric prescriptions
2021 · Amira B. Kassem, Haitham Saeed, et al. · Saudi Pharmaceutical Journal · 10
PDF
Repurposing of high-dose N-acetylcysteine as anti-inflammatory, antioxidant and neuroprotective agent in moderate to severe traumatic brain injury patients: a randomized controlled trial
2025 · Alaa Refaat Gouda, Noha A El-Bassiouny, et al. · Inflammopharmacology · 8
PDF
Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction
2024 · Zeinab M. Elhadad, Amira B. Kassem, et al. · Cardiovascular Drugs and Therapy · 7
PDF
Impact of Alpha Lipoic Acid as an Adjuvant Therapy on Inflammation and Fibrosis in Type 2 Diabetic Patients with Ischemic Cardiomyopathy: A Randomized Controlled Trial
2025 · Aya M. Shama, Noha A. El-Bassiouny, et al. · Journal of Dietary Supplements · 4
Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients
2025 · Naglaa F. Gomaa, Rehab H. Werida, et al. · Supportive Care in Cancer · 4
PDF
Assessment of a new strategy for catalyzing deprescribing in community pharmacies
2021 · Osama Mohamed Ibrahim, Nadia Al Mazrouei, et al. · Journal of the American Pharmacists Association · 4
Studying the association between some genetic polymorphisms and Doxorubicin-Induced Cardiotoxicity
2024 · Enas A. El-Shorbagy, Amira B. Kassem, et al. · International Journal of Clinical Medical Research · 3
Dapagliflozin effect on anemia outcomes in patients with diabetes and CKD
2025 · Ramy Ibrahim Elwaraky, Amira B. Kassem, et al. · Future Journal of Pharmaceutical Sciences · 2
PDF
The impact of CBR3 (rs1056892) and ABCC1 (rs45511401) genetic polymorphisms on doxorubicin-induced cardiotoxicity and the potential role of brain natriuretic peptide as an early cardiac biomarker in breast cancer patients
2025 · Enas A. El-Shorbagy, Noha A. El-Bassiouny, et al. · Expert Opinion on Drug Metabolism & Toxicology · 2
Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation
2024 · Mohamed A. Eltelbanei, Noha A. El-Bassiouny, et al. · BMC Cancer · 2
PDF
Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients
2024 · Sherouk M. Okda, Noha A. El‐Bassiouny, et al. · British Journal of Clinical Pharmacology · 2
PDF
The potential impact of clindamycin on neurosurgery patients: a randomized controlled trial
2025 · Lobna w. Alam El-Din, Noha A. El-Bassiouny, et al. · Inflammopharmacology · 1
PDF
Pharmacogenomic insights: IL-23R and ATG-10 polymorphisms in Sorafenib response for hepatocellular carcinoma
2025 · Asmaa M. El-Sheshtawy, Rehab H. Werida, et al. · Clinical and Experimental Medicine · 1
PDF
Novel Potential Drug Interactions with Bisoprolol in Hospitalized Acute Coronary Syndrome Patients
2024 · Sherouk Okda, Amira Kassem, et al. · Bulletin of Pharmaceutical Sciences Assiut · 1
PDF
Genetic Polymorphisms and Risk of Cardiovascular Disease
2023 · Sherouk M Okda, Amira B Kassem, et al. · International Journal of Clinical Medical Research · 1
PDF
Metformin Alleviates Chemotherapy-Induced Toxicities in Non-Diabetic Breast Cancer Patients: A Randomized Controlled Study
2023 · Mahmoud El-Mas, Amira B. Kassem, et al. · Journal of Pharmacology and Experimental Therapeutics · 1
PDF
Clinical Preservation of Patient-Reported Outcomes with Adjunctive Fenofibrate in Breast Cancer Patients Receiving Anthracycline and Taxane Regimens: A Randomized Controlled Trial
2026 · Entesar K. Attia, Rehab H. Werida, et al. · Journal of Advanced Medical and Pharmaceutical Research
Effect Of Adding Vildagliptin Versus Glimepiride To On-Going Metformin Therapy On Copeptin And Fetuin-A In Type 2 Diabetic Patients: A Randomized Controlled Trial
2026 · Zeyad M. Beshara, Noha A El‑Bassiouny, et al. · Journal of Advanced Medical and Pharmaceutical Research
Works count: 36
Citation count: 255
H-index: 8
I10-index: 8
Year
Topic
Type